Subject
Pharmacology,General Medicine
Reference51 articles.
1. Emerging mechanisms of molecular pathology in ALS;Peters;J. Clin. Invest.,2015
2. Motor neuron disease with predominantly upper extremity involvement: a clinicopathological study;Sasaki;Acta Neuropathol.,1999
3. G.M. Ringholz, S.H. Appel, M. Bradshaw, N.A. Cooke, D.M. Mosnik, P.E. Schulz, Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology., Neurology. 65(4): (n.d.) 586–590. https://doi.org/5(4):586–90. doi: 10.1212/01.wnl.0000172911.39167.b6. PMID: 16116120.
4. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis;Brooks;Amyotroph Lateral Scler Other Motor, Neuron Disord,2000
5. Ionic homeostasis maintenance in ALS: Focus on new therapeutic targets;Sirabella;Front. Neurosci.,2018